Literature DB >> 15281338

Molecular pathology of the pituitary. Development and functional differentiation of pituitary adenomas.

Robert Yoshiyuki Osamura1, Noboru Egashira, Shunsuke Miyai, Michio Yamazaki, Susumu Takekoshi, Naoko Sanno, Akira Teramoto.   

Abstract

This review article describes functional differentiation of the pituitary cells and pituitary adenomas with special emphasis on transcription factors and co-factors. Human pituitary adenomas generally follow the combination of transcription factors and co-factors, which are similar to those of physiologic anterior pituitary cells. On very rare occasions, the single pituitary adenoma produces two hormones, which belong to different cell lineage 'trans-cell lineage'. Basic mechanism for this was considered to be 'aberrant expression' of transcription factors, i.e. NeuroD1 and Pit-1. This was experimentally supported by the induction of GH (mRNA and protein) in AtT-20 cells by transfecting Pit-1 gene. Various mechanisms have been reported for the experimental pituitary oncogenesis. Among these, GHRH has been emphasized as one of oncogenic factors for both human GHomas as well as in the transgenic animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15281338     DOI: 10.1159/000079036

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  5 in total

1.  Pituitary blastoma: a unique embryonal tumor.

Authors:  Bernd W Scheithauer; E Horvath; T W Abel; Y Robital; S-H Park; R Y Osamura; C Deal; R V Lloyd; K Kovacs
Journal:  Pituitary       Date:  2012-09       Impact factor: 4.107

Review 2.  Recent progress in studies of pituitary tumor pathogenesis.

Authors:  Takeo Minematsu; Shunsuke Miyai; Hanako Kajiya; Masanori Suzuki; Naoko Sanno; Susumu Takekoshi; Akira Teramoto; Robert Y Osamura
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

3.  Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution.

Authors:  Robert Y Osamura; Noboru Egashira; Hanako Kajiya; Mao Takei; Maya Tobita; Takashi Miyakoshi; Chie Inomoto; Susumu Takekoshi; Akira Teramoto
Journal:  Acta Histochem Cytochem       Date:  2009-08-11       Impact factor: 1.938

4.  Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Authors:  Hua Gao; Fei Wang; Xiaolei Lan; Chuzhong Li; Jie Feng; Jiwei Bai; Lei Cao; Songbai Gui; Lichuan Hong; Yazhuo Zhang
Journal:  BMC Cancer       Date:  2015-04-12       Impact factor: 4.430

Review 5.  Pathology of the human pituitary adenomas.

Authors:  Robert Y Osamura; Hanako Kajiya; Mao Takei; Noboru Egashira; Maya Tobita; Susumu Takekoshi; Akira Teramoto
Journal:  Histochem Cell Biol       Date:  2008-08-08       Impact factor: 4.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.